Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Levamlodipine Besylate in Healthy Chinese Subjects
NCT04411875Phase 1Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Nov 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Levamlodipine in hypertension (HTN) (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Peak Plasma Concentration at 64 days, Area under the plasma concentration versus time curve from time zero to time t at 64 days and 1 more. Started Nov 2018; status: completed.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04411875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411875.